secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001628280-25-052068
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem TTM revenue $141.1M, AEBITDA $30.2M; guides 6-8% FY2025 growth
-------------------------------------------------------------------------

- TTM revenue through Sep 30, 2025: $141.1M; estimated 2025 revenue grows 6-8% over 2024's $134.9M.
- Adjusted EBITDA TTM $30.2M (21.4% margin); estimated 2025 AEBITDA margin >20% of revenue.
- Patient Services net revenue TTM $85.4M; Device Solutions $55.7M; gross margin 55.4%.
- Stock repurchases of $9.7M under $20M program through Sep 30, 2025; program expires Jun 30, 2026.
- ERP upgrade investment estimated $2.6M in 2025 ($3.3M cumulative); expected completion Q1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025052068/0001628280-25-052068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025052068/infu-20251113.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-052068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer